Laza Medical Secures $36M in Series A Funding to Revolutionize Cardiovascular Interventions with AI-Powered Robotic Imaging.
Laza Medical, a Shifamed portfolio company, is pioneering in the development of a high-quality, AI-powered robotic imaging solution for cardiovascular interventions.
Company Name: Laza Medical
Location: Los Gatos, CA
Sector: Medical Technology
Funding Details: Raised $36M in Series A funding, led by The Capital Partnership (TCP) with participation from GE HealthCare, PA MedTech VC fund, Unorthodox Ventures, and Dara Holdings.
Purpose of Investment: To accelerate product development and expand the team.
Leadership: General Manager Pablo Garcia, a seasoned medtech executive with a background in digital solutions at Johnson & Johnson and as a technical co-founder of Verb Surgical.
Product: AI-powered robotically-assisted imaging solution for cardiovascular interventions, aiming to optimize procedural workflows and improve imaging standards.
About Company: Laza Medical, a Shifamed portfolio company, is pioneering in the development of a high-quality, AI-powered robotic imaging solution for cardiovascular interventions. Their technology focuses on enhancing procedural workflows and setting new standards in imaging quality for these critical procedures.
Innovation and Impact:
- AI and Robotic Assistance: Combines advanced AI algorithms with robotic assistance to improve accuracy and efficiency in cardiovascular interventions.
- Optimized Procedural Workflows: Aims to streamline the procedural process, reducing time and potential for error.
- Elevated Imaging Standards: Focuses on providing superior imaging quality, crucial for successful cardiovascular interventions.
Leadership Insight: Pablo Garcia brings a wealth of experience from the medtech industry, including his role in developing surgical robotics platforms, to lead Laza Medical towards achieving its vision.